Whether these drugs move mood in either direction has been argued over for two years, and most of the argument is conducted without naming a comparator. A target trial emulation in US Medicare data makes the point unavoidable: it asked the same question twice, against two different drug classes, and got two different answers [1]. It is a useful corrective to the way this claim usually reaches a seller’s page.
Two comparisons, two answers
Adults aged 66 and over with type 2 diabetes were matched on propensity score. Against DPP-4 inhibitors, across 13,711 matched pairs, the rate difference was −5.78 cases of depression per 1,000 person-years (95% CI −10.49 to −1.07), a hazard ratio of 0.90 (95% CI 0.82 to 0.98). That interval clears 1.
Against SGLT2 inhibitors, across 14,665 pairs, the rate difference was 3.48 per 1,000 person-years (95% CI −0.81 to 7.78), a hazard ratio of 1.07 (95% CI 0.98 to 1.18). That interval spans 1. So the honest sentence is that GLP-1 use carried a modestly lower depression risk than one comparator and no detectable difference against another.
Why the comparator is the finding
A drug is never tested against nothing in this kind of study. Everyone in both arms was being treated. So a hazard ratio here describes a choice between two treatments, not the effect of taking one. Reading 0.90 as “GLP-1 drugs protect against depression” drops the clause that carries the meaning — the same omission we found where gout was compared across classes and where a kidney-stone comparison ran the other way.
The authors rule this market out themselves
The stated limitations include unmeasured confounders such as HbA1c and body mass index, and limited generalizability to younger people and to those taking the drug for obesity rather than diabetes. That second clause is this market, named by the paper as out of scope. Everyone studied was 66 or older with type 2 diabetes.
Which leaves the same practical point as the rest of the mood evidence, including the suicidality signal: what matters is whether the service you are paying can be reached by someone qualified if your mood changes. That is a question about the seller, and most of them do not answer it — a gap counted in questions they leave open.